Summary

In The Netherlands, the rates of thrombolysis for ischemic stroke in are not optimal, despite guidelines recommending its use. This article discusses results from the Promoting Acute Thrombolysis for Ischaemic Stroke [PRACTISE; ISRCTN 20405426] trial, which evaluated the effectiveness of an intensive multifaceted implementation strategy aimed at increasing the number of patients who are treated with thrombolysis.